Highly Active Antiretroviral Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
Condition: HIV InfectionInterventions: Drug: Vaccination; Drug: PlaceboSponsor: Hospital Clinic of BarcelonaCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2011 Category: Research Source Type: clinical trials

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: Ribavirin; Biological: Pegylated Interferon Alfa-2a; Drug: Highly Active Antiretroviral Therapy (HAART)Sponsor: Vertex Pharmaceuticals IncorporatedTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: Truvada and KaletraSponsors: University of Alberta; Abbott; Gilead Sciences; Canadian Institutes of Health Research (CIHR)Active, not recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2011 Category: Research Source Type: clinical trials

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: Truvada and KaletraSponsors: University of Alberta; Abbott; Gilead Sciences; Canadian Institutes of Health Research (CIHR)Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2011 Category: Research Source Type: clinical trials